Ian T. Clark

Insider Reports History

Entity
Individual
Location
Solazyme, Inc., 225 Gateway Blvd., South San Francisco, CA
Signature
/s/ John G. Saia, as attorney-in-fact for Ian T. Clark
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian T. Clark:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GoodRx Holdings, Inc. Director Restricted Stock Unit 51.7K $406K $7.84 Jul 8, 2024 Direct
Guardant Health, Inc. Director Common Stock 8.44K $248K $29.44 Nov 12, 2024 By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Guardant Health, Inc. Director Restricted Stock Units 8.09K $225K $27.87 Jun 12, 2024 Direct
GoodRx Holdings, Inc. Director Class A Common Stock 25.9K $203K $7.84 Jul 8, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Common stock 6.55K $142K $21.64 May 20, 2022 Direct
Guardant Health, Inc. Director Common Stock 0 $0 $29.44 Nov 12, 2024 Direct
Olema Pharmaceuticals, Inc. Director Stock Option (right to buy) 23K Jun 14, 2024 Direct
AVROBIO, Inc. Director Stock Option (Right to Buy) 17.6K Jun 6, 2023 Direct
Corvus Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 15K Jun 13, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Restricted stock unit 0 $24.79 May 20, 2022 Direct
Guardant Health, Inc. Director Stock Option (Right to Buy) 0 Nov 12, 2024 Direct

Insider Reports Filed by Ian T. Clark

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GH Guardant Health, Inc. Nov 12, 2024 6 -$240K 4 Nov 14, 2024 Director
GDRX GoodRx Holdings, Inc. Jul 8, 2024 2 $0 4 Jul 10, 2024 Director
GDRX GoodRx Holdings, Inc. Jul 8, 2024 0 $0 3 Jul 10, 2024 Director
OLMA Olema Pharmaceuticals, Inc. Jun 14, 2024 1 $0 4 Jun 18, 2024 Director
CRVS Corvus Pharmaceuticals, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
GH Guardant Health, Inc. Jun 12, 2024 4 $0 4 Jun 13, 2024 Director
KYTX Kyverna Therapeutics, Inc. Feb 7, 2024 0 $0 3 Feb 7, 2024 Director
CRVS Corvus Pharmaceuticals, Inc. Dec 6, 2023 1 $0 4 Dec 8, 2023 Director
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2023 1 $0 4 Jun 21, 2023 Director
CRVS Corvus Pharmaceuticals, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
GH Guardant Health, Inc. Jun 14, 2023 4 $0 4 Jun 16, 2023 Director
AVRO AVROBIO, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
CRVS Corvus Pharmaceuticals, Inc. Aug 11, 2022 1 $0 4 Aug 15, 2022 Director
OLMA Olema Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4/A Jun 27, 2022 Director
GH Guardant Health, Inc. Jun 15, 2022 4 $0 4 Jun 17, 2022 Director
CRVS Corvus Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
AVRO AVROBIO, Inc. Jun 8, 2022 2 $0 4 Jun 10, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 20, 2022 2 $0 4 May 24, 2022 Director
CRVS Corvus Pharmaceuticals, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 Director
GH Guardant Health, Inc. Sep 1, 2021 3 -$135K 4 Sep 3, 2021 Director
GH Guardant Health, Inc. Jun 29, 2021 5 -$995K 4 Jul 1, 2021 Director
OLMA Olema Pharmaceuticals, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2022 Director
GH Guardant Health, Inc. Jun 16, 2021 2 $0 4 Jun 21, 2021 Director
CRVS Corvus Pharmaceuticals, Inc. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director
AVRO AVROBIO, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
OLMA Olema Pharmaceuticals, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 28, 2021 2 $0 4 Jun 2, 2021 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 20, 2021 2 $0 4 May 24, 2021 Director